Wcm Investment Management, LLC Phathom Pharmaceuticals, Inc. Transaction History

Wcm Investment Management, LLC

  • $38.6 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 26, 2022
SELL
$17.83 - $33.15 $1.86 Million - $3.46 Million
-104,380 Closed
0 $0
Q3 2021

Nov 02, 2021
BUY
$30.69 - $36.83 $12,061 - $14,474
393 Added 0.38%
104,380 $3.35 Million
Q2 2021

Aug 05, 2021
BUY
$32.66 - $39.87 $3.4 Million - $4.15 Million
103,987 New
103,987 $3.52 Million

Others Institutions Holding PHAT

# of Institutions
144
Shares Held
73.6M
Call Options Held
42.3K
Put Options Held
45.7K
View Full List

About Phathom Pharmaceuticals, Inc.

PHAT Quotes by TradingView
  • Ticker PHAT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,175,200
  • Market Cap $350M
  • Description
  • Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also develo...
More about PHAT
Track This Portfolio

Track Wcm Investment Management, LLC Portfolio

Follow Wcm Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wcm Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wcm Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email